News

Dr Lalchandani Labs Limited informed the BSE Limited that it has received a compliance certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories & Participants) Regulations, 2018, from Cameo Corporate Services Limited, its registrar and share transfer agent, for the quarter ended September 30, 2026.

Dr Lalchandani Labs Limited informed the BSE Limited that the trading window for dealing in the company`s securities will be closed from October 1, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the half year ended September 30, 2026.

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 30 May 2026.

Dr Lalchandani Labs has postponed the meeting of the Board of Directors which was scheduled to be held on 22 December 2025. The meeting will now be held on 20 January 2026.Powered by Capital Market - Live News

Dr Lalchandani Labs will hold a meeting of the Board of Directors of the Company on 22 December 2025.Powered by Capital Market - Live News